Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms - 27/10/20
pages | 12 |
Iconographies | 2 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | The antitumor active components of Hedyotis diffusa Willd were screened out. |
• | Multiple components developed antitumor activities via multi-target and multi-pathway. |
• | We provided the latest evidence for molecular mechanisms of antitumor activities. |
• | We provide a reference for the further development and utilization of H. diffusa. |
• | The review enumerated the clinical application and potentially toxic ingredients. |
Abstract |
Cancer is a major cause of death in the world. Chemotherapy can extend the life of cancer patients to some extent, but the quality of life is reduced. Therefore, the quest for more efficient and less toxic medication strategies is still at the forefront of current research. Hedyotis diffusa Willd (HDW), a Chinese herb medicine, has received great attention in the past two decades and has been well documented in clinics for antitumor activity in a variety of human cancers. This review discussed a total of 58 different kinds of active antitumor components isolated from HDW, including iridoids, flavonoids, flavonol glycosides, anthraquinones, phenolic acids, and their derivatives, sterols, and volatile oils. Their antitumor activities include inhibition of tumor cell proliferation, induction of tumor cell apoptosis and tumor angiogenesis, regulation of the host immune response, anti-inflammatory and antioxidant, and protective autophagy. Besides, we provide up-to-date and systematic evidence for HDW antitumor activities and the possible underlying molecular mechanisms and reference for further development of novel drugs and dosage formulation in control of human cancers.
Le texte complet de cet article est disponible en PDF.Keywords : Hedyotis diffusa Willd, Antitumor activity, Apoptosis, Proliferation, Cell cycle termination, Anti-inflammation
Plan
Vol 130
Article 110735- octobre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?